AGŐćČ˹ٷ˝

STOCK TITAN
  1. Home
  2. Sec-filings
  3. EXAS
  4. [144] Exact Sciences Corp SEC Filing

[144] Exact Sciences Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source:

Stock EXAS logo
Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

#1397 Ranked by Market Cap
N/A Ranked by Dividends

EXAS Latest News

Jul 31, 2025
Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus� Test
Jul 14, 2025
Exact Sciences Schedules Second Quarter 2025 Earnings Call
Jul 9, 2025
Exact Sciences Announces Medicare Coverage for Oncodetect� Molecular Residual Disease Test in Colorectal Cancer
May 28, 2025
Exact Sciences Announces Expanded Clinical Validation of the Oncodetect� Test and Molecular Residual Disease Innovation Roadmap
May 27, 2025
Exact Sciences to Participate in June Investor Conference

EXAS Latest SEC Filings

Jul 11, 2025
[S-8 POS] Exact Sciences Corp SEC Filing
Jul 11, 2025
[S-8] Exact Sciences Corp Employee Benefit Plan Registration

EXAS Stock Data

8.83B
186.21M
1.07%
100.78%
5.74%
Diagnostics & Research
Services-medical Laboratories
United States
MADISON